高级检索
当前位置: 首页 > 详情页

Safety of repeated low-level red-light therapy for children with myopia

| 导出 | |

文献详情

资源类型:
Pubmed体系:
单位: [1]Department of Ophthalmology,Tongji Hospital,Tongji Medical College,Huazhong,University of Science and Technology,Wuhan,430030,China [2]Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong, University of Science and Technology, Wuhan, 430030, China
出处:
ISSN:

关键词: Myopia control Repeated low-level red-light therapy Electroretinography Photoreceptor outer segment

摘要:
To investigate the safety of repetitive low-level red-light therapy (RLRLT) in children with myopia.Children with myopia were assigned to the RLRL and control groups. Axial length (AL) and spherical equivalent refraction (SER) were followed up at 3-, 6-, and 12-month. To evaluate the safety of RLRLT, at 6 and 12 months in the RLRL group, multifocal electroretinography (mfERG) and contrast sensitivity were recorded. Furthermore, optical coherence tomography was used to measure the relative reflectance of the ellipsoid zone (rEZR), photoreceptor outer segment (rPOSR), and retinal pigment epithelium (rRPER).A total of 108 children completed the trial (55 in the RLRL group and 53 in the control group). After 3, 6, and 12 months, AL was shorter and SER less myopic in the RLRL group than in the control group. Regarding the safety of the RLRLT, the response density and amplitude of the P1 wave of the first ring of the mfERG increased significantly at 6 months (P = 0.001 and P = 0.017, respectively). At 6 and 12 months, contrast sensitivity at the high spatial frequency increased. Moreover, the rEZR increased significantly at 6 months (P = 0.029), the rPOSR increased significantly at 6 and 12 months (both P < 0.001), and the increase in rPOSR was greater with greater AL regression.Based on retinal function and structure follow-up, RLRLT was safe within 12 months. However, rEZR and rPOSR increased, the effects of this phenomenon requires further observation.Copyright © 2024. Published by Elsevier B.V.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
第一作者:
第一作者单位: [1]Department of Ophthalmology,Tongji Hospital,Tongji Medical College,Huazhong,University of Science and Technology,Wuhan,430030,China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:432 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)